Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Diabetes Prevention Post-GDM
NCT05280496Phase 3Completed
- Sponsor
- Tufts Medical Center
- Start
- Jun 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Tufts Medical Center. Started Jun 2022; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05280496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280496.